Global Constipation Treatment Sales Market Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Constipation Treatment Sales Market Report 2024
Market Analysis and InsightsGlobal Constipation Treatment Market
Constipation refers to bowel movements that are infrequent or hard to pass. The stool is often hard and dry. Other symptoms may include abdominal pain, bloating, and feeling as if one has not completely passed the bowel movement.
Due to the COVID-19 pandemic, the global Constipation Treatment market size is estimated to be worth US$ 6198.2 million in 2024 and is forecast to a readjusted size of US$ 8330.8 million by 2034 with a CAGR of 3.9% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Chronic Idiopathic Constipation accounting for % of the Constipation Treatment global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
The United States Constipation Treatment market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key players of Constipation Treatment include Takeda, SGYP, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Abbott, AstraZeneca, Cosmo Pharmaceuticals, Sanofi and Daewoong, etc. In 2024, the global top five players have a share approximately % in terms of revenue.
In United States, in terms of revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Constipation Treatment Scope and Market Size
The global Constipation Treatment market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Constipation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2034.
Segment by Type
Chronic Idiopathic Constipation
Irritable Bowel Syndrome with Constipation
Opioid Induced Constipation
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
Takeda
SGYP
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Abbott
AstraZeneca
Cosmo Pharmaceuticals
Sanofi
Daewoong
Bayer
Prestige Brands
Janssen Pharmaceutical
Shionogi
Albireo Pharma
Renexxion
Constipation refers to bowel movements that are infrequent or hard to pass. The stool is often hard and dry. Other symptoms may include abdominal pain, bloating, and feeling as if one has not completely passed the bowel movement.
Due to the COVID-19 pandemic, the global Constipation Treatment market size is estimated to be worth US$ 6198.2 million in 2024 and is forecast to a readjusted size of US$ 8330.8 million by 2034 with a CAGR of 3.9% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Chronic Idiopathic Constipation accounting for % of the Constipation Treatment global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
The United States Constipation Treatment market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key players of Constipation Treatment include Takeda, SGYP, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Abbott, AstraZeneca, Cosmo Pharmaceuticals, Sanofi and Daewoong, etc. In 2024, the global top five players have a share approximately % in terms of revenue.
In United States, in terms of revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Constipation Treatment Scope and Market Size
The global Constipation Treatment market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Constipation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2034.
Segment by Type
Chronic Idiopathic Constipation
Irritable Bowel Syndrome with Constipation
Opioid Induced Constipation
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Takeda
SGYP
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Abbott
AstraZeneca
Cosmo Pharmaceuticals
Sanofi
Daewoong
Bayer
Prestige Brands
Janssen Pharmaceutical
Shionogi
Albireo Pharma
Renexxion